drugset / Trial / NCT04360174
CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension
Non-randomizedSequentialOpen-labelTreatment
Summary
To assess the safety, tolerability and efficacy of a single sustained release dose of OTX-TIC, a sustained release travoprost drug product, in subjects with primary open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2018-04-25
- Primary completion
- 2021-05-24
- Completion
- 2021-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 5 ug | Other |
| Subject | Travoprost | Other / unclassified | 15 ug | Other |
| Subject | Travoprost | Other / unclassified | 26 ug | Other |